So, we carried out a hospital-based, case-control study including 1,853 breast cancer patients and 1,992 cancer free controls to investigate the contribution of the five polymorphisms of CD44 to susceptibility to and prognosis of breast cancer. The gene discussed is CD44; the disease is breast cancer.